DOI:
10.1055/s-00044025
Annals of the National Academy of Medical Sciences (India)
LinksClose Window
References
Sriram K, Insel PA.
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.
Clin Pharmacol Ther 2020;
108 (02) 236-241
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.